Clinical Investigation in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
Clinical Investigation in Colombia
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Investigation in Colombia

Clinical Investigation in Colombia – Full Service CRO

Colombia has emerged as a key player in the global clinical research industry in recent years, offering a range of benefits for drug developers looking to conduct clinical trials in the region. With a large and diverse patient population, a favorable regulatory environment, and a well-established research infrastructure, Colombia has become an attractive location for drug developers looking to conduct clinical investigations.

One of the key advantages of conducting clinical trials in Colombia is the country’s large and diverse patient population. With a population of over 50 million people, Colombia is home to a wide range of ethnic groups and socio-economic backgrounds. This diversity makes it an attractive location for drug developers looking to recruit patients for clinical trials, as it allows for a broad range of patient demographics to be included in studies.

Another key advantage of conducting clinical investigations in Colombia is the country’s favorable regulatory environment. The Colombian government has taken steps in recent years to promote the growth of the clinical research industry, with the introduction of new regulations aimed at streamlining the clinical trial approval process and improving patient safety. As a result, drug developers looking to conduct clinical trials in Colombia can expect to encounter a more straightforward and efficient regulatory process than in many other countries.

In addition to its favorable regulatory environment, Colombia also boasts a well-established research infrastructure, including a number of world-class research institutions and experienced clinical research organizations (CROs). These organizations offer a range of services to drug developers looking to conduct clinical trials in Colombia, including study design, patient recruitment, and data management.

Despite these advantages, conducting clinical investigations in Colombia can also present some unique challenges. One of the key challenges is the country’s geography, which can make it difficult to access certain regions of the country. This can be particularly challenging for drug developers looking to conduct clinical trials in remote or rural areas of Colombia, where patient populations may be more difficult to reach.

Another challenge associated with conducting clinical trials in Colombia is the country’s complex social and political environment. While the Colombian government has taken steps to promote the growth of the clinical research industry, the country still faces significant challenges related to security, corruption, and political instability.

Drug developers looking to conduct clinical trials in Colombia must therefore take steps to ensure that their studies are conducted safely and ethically, and that they comply with local regulations and international standards.

Despite these challenges, Colombia’s clinical investigation industry is expected to continue to grow in the coming years, as drug developers look for new locations to conduct clinical trials. With a large and diverse patient population, a favorable regulatory environment, and a well-established research infrastructure, Colombia is well-positioned to play an important role in the global clinical research industry in the years to come.

Clinical Investigation in Colombia

Clinical Investigation in Colombia

Clinical Investigation in Colombia

To ensure the success of clinical trials in Colombia, drug developers must work closely with local partners and experienced CROs to navigate the country’s complex regulatory environment and cultural norms. By taking a proactive and collaborative approach to clinical investigations in Colombia, drug developers can ensure that their studies are conducted safely, ethically, and in compliance with local regulations and international standards.

It’s also worth noting that Colombia has been proactive in promoting the growth of its clinical investigation industry. The country has developed a number of initiatives aimed at promoting clinical research and improving patient access to innovative therapies.

For example, the Colombian government has established a national clinical trial registry, which provides researchers and patients with information about ongoing clinical trials in the country.

Additionally, the Colombian Ministry of Health has implemented a number of initiatives aimed at improving the quality and safety of clinical trials, including the development of guidelines for good clinical practice (GCP) and the establishment of a national system for monitoring the safety of clinical trials.

One area where Colombia has shown particular strength is in the conduct of clinical trials in oncology. The country has a number of world-class cancer research centers and has established itself as a leader in the development of innovative cancer therapies.

This has led to a growing interest in conducting clinical trials in oncology in Colombia, as drug developers look to take advantage of the country’s expertise in this area.

However, there are also some potential risks associated with conducting clinical investigations in Colombia. For example, the country has a relatively high incidence of infectious diseases, which can present a risk to both patients and researchers.

Additionally, the country’s complex social and political environment can make it difficult to conduct clinical trials in certain regions of the country, particularly those affected by violence or political instability.

To address these challenges, drug developers looking to conduct clinical trials in Colombia must take a proactive approach to risk management. This includes ensuring that appropriate measures are in place to protect the safety of patients and researchers, as well as complying with local regulations and international standards for the conduct of clinical trials.

Overall, Colombia’s clinical investigation industry offers a range of benefits for drug developers looking to conduct clinical trials in the region. With a large and diverse patient population, a favorable regulatory environment, and a well-established research infrastructure, Colombia is well-positioned to play an important role in the global clinical research industry.

However, drug developers must also be aware of the potential risks associated with conducting clinical trials in Colombia and take appropriate measures to manage these risks. By working closely with local partners and experienced CROs, drug developers can ensure that their studies are conducted safely, ethically, and in compliance with local regulations and international standards.

 

Clinical Investigation in Colombia

Source: Pro Colombia

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Investigation in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Investigation in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Investigation in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Investigation in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Investigation in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Investigation in Colombia

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Investigation in Colombia

The Cohortias Team

Clinical Investigation in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Investigation in Colombia

Network & Partnerships